Zinc deficiency anemia and effects of zinc therapy in maintenance hemodialysis patients

Therapeutic Apheresis and Dialysis

Volumn 13, Issue 3, 2009, Pages 213-219

  Fukushima, Tatsuo ^a   Horike, Hideyuki ^b   Fujiki, Shigeatsu ^a   Kitada, Shingo ^a   Sasaki, Tamaki ^b   Kashihara, Naoki ^b  

^a Tsuoyama Chuo Hospital   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

EPO resistant anemia; Renal anemia; Zinc deficiency; Zinc supplementation

Indexed keywords

HEMOGLOBIN; IRON; POLAPREZINC; RECOMBINANT ERYTHROPOIETIN; ZINC;

ADJUVANT THERAPY; ADULT; AGED; ANEMIA; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CONFERENCE PAPER; DIARRHEA; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL; HUMAN; INTOXICATION; IRON DEFICIENCY; IRON THERAPY; JAPAN; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PARAMETER; PRIORITY JOURNAL; REFRACTORY ANEMIA; TREATMENT RESPONSE; ZINC BLOOD LEVEL; ZINC DEFICIENCY; ZINC DEFICIENCY ANEMIA;

AGED; ANEMIA; ANEMIA, IRON-DEFICIENCY; CARNOSINE; DIARRHEA; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IRON COMPOUNDS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RENAL DIALYSIS; ZINC; ZINC COMPOUNDS;

EID: 66549088736     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00656.x     Document Type: Conference Paper

References (25)

1. Iseki K, Ikemiya Y, Iseki C, Takishita S. Haematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 2003 18 : 899 905. (Pubitemid 36592530)
2. Silverberg D, Wexler D, Blum M et al. The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant 2003 18 (Suppl. 8 viii7 12.
3. Robinson BM, Joffe MM, Berns JS et al. Anemia and mortality in hemodialysis patients. Accounting for morbidity and treatment variables update over time. Kidney Int 2005 68 : 2323 30.
4. Zumkley H, Bertram HP, Lison A et al. Aluminum, zinc and copper concentration in plasma in chronic renal insufficiency. Clin Nephrol 1979 12 : 18 21. (Pubitemid 9211845)
5. Hosokawa S, Yoshida O. Effect of erythropoietin on trace elements in patients with chronic renal failure undergoing hemodialysis. Nephron 1993 65 : 414 17.
6. Bennett CL, Luminari S, Nissenson AR et al. Pure Red-Cell Aplasia and Epoetin Therapy. N Engl J Med 2004 351 : 1403 8.
7. Schellekens H. Factors influencing the immunogenicity of therapeutic proteins. Nephrol Dial Transplant 2005 20 (Suppl. 6 vi3 9. Review.
8. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005 352 : 1011 23.
9. Caville I. Intravenous iron as adjuvant therapy: a two-edged sword? Nephrol Dial Transplant 2003 18 (Suppl. 8 viii24 28.
10. Go AS, Chertow GM, Fan D et al. Chronic Kidney Disease and the risk of death, cardiovascular event and hospitalization. N Engl J Med 2004 351 : 1296 305.
11. Prasad AS, Halsted JA, Nadimi M. Syndrome of iron deficiency anemia, hepatosplenomegary, dwarfism and geophagia. Am J Med 1961 31 : 532 46.
12. Nishiyama S, Inomoto T, Nakamura T, Higashi A, Matsuda I. Zinc status relates to hematological effects in women endurance runners. J Am Coll Nutr 1996 15 : 359 63.
13. Xia J, Browning JD, O'Dell BL. Decreased plasma membrane thiol concentration is associated with increased osmotic fragility of erythrocyte in zinc-deficient rats. J Nutr 1999 129 : 814 19.
14. Polenakovic M, Sikole A. Is erythropoietin a survival factor for red blood cells? J Am Soc Nephrol 1996 7 : 1178 82.
15. Lee MS, Gippert KV, Soman KV et al. Three-dimensional solution structure of a single zinc finger DNA-binding domain. Science 1989 245 : 635 7.
16. Anguita E, Hughes J, Heyworth C et al. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J 2004 23 : 2841 52.
17. Suzuki H, Tashiro S, Hira S et al. Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. EMBO J 2004 23 : 2544 53.
18. MacDonald RS. The role of zinc in growth and cell proliferation. J Nutr 2000 130 (Suppl. 5 S1500 8.
19. Mahajan SK, Bowersox EM, Rye DL et al. Factors underlying abnormal zinc metabolism in uremia. Kidney Int Suppl 1989 27 : S269 273.
20. Maroni BJ. Protein restriction in the pre-end-stage renal disease (ESRD) patient: who, when, how, and the effect on subsequent ESRD outcome. J Am Soc Nephrol 1998 9 (Suppl. S100 6.
21. De Vecchi AF, Dratwa M, Wiedemann ME. Healthcare systems and end-stage renal disease (ESRD) therapies - an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant 1999 14 (Suppl. 6 31 641.
22. Thamer M, Zhang Y, Kaufman J. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA 2007 297 : 1667 74.
23. Yanagisawa H, Nodera M, Wada O. Zinc deficiency aggravates tubulointerstitial nephropathy caused by ureteral obstruction. Biol Trace Elem Res 1998 65 : 1 6. (Pubitemid 29013321)
24. Yanagisawa H, Moridaira K, Wada O. Zinc deficiency further increases the enhanced expression of endothelin-1 in glomeruli of the obstructed kidney. Kidney Int 2000 58 : 575 86.
25. Sato M, Yanagisawa H, Nojima Y et al. Zinc deficiency aggravates hypertension in spontaneously hypertensive rats: possible role of Cu/Zn superoxide dismutase. Clin Exp Hypertens 2002 24 : 355 70.